Era of partial replacement of doctors gaining impetus
Bio Spectrum|February 2020
Technology is assisting healthcare providers to make phenomenal gains by improving outcome in treatments by accurate diagnosis and treatment of diseases. Experts say that technological advancement in healthcare like adoption of digital pathology is expected to be the topmost choice in the healthcare industry, as it has proven to reduce the workload of physicians and clinicians. Additionally, it has also resulted in squeezing down the patient’s expenses due to more systemic approach in health systems enabled by technological developments.
Jyoti Pandey
Era of partial replacement of doctors gaining impetus

In 2019, the Indian government announced the shortage of doctors i.e. one doctor for 1,457 people, which is lower than the World Health Organisation (WHO) norms of 1:1000. In order to reach the recommended WHO doctor-patient ratio, India will need 2.3 million doctors by 2030. Nevertheless, the latest significant progress of the private health sector in India has come at a time when public spending on healthcare at 0.9 percent of gross domestic product (GDP).

Privatization leads to a sharp rise in the health expenditure in arrears to the increased cost of medical tests and medical consultations. Inefficient healthcare infrastructure in India is another contributing factor that restraints accessible healthcare delivery. Synopsizing in a sentence lack of trained medical professionals, low income, and inadequate medical facilities and infrastructure are the major challenges faced for accessible healthcare delivery in India.

Dr. Chirat Bhoraj, CEO Tricog Health, Bengaluru says, “The healthcare system suffers from a lack of affordable, accessible (quality) care for all, medical expertise will remain a scare recourse in the near-term, magnifying the impact of doctor and making them superefficient is an attractive solution, aggregating data enabled by the judicious use of technology like Artificial Intelligence (AI) will help to achieve this”.

The concern over these challenges is now putting more emphasis on innovative strategies and is expected to be rescued by the growing adoption of technology. According to Future Health Index, India accounted for 76 percent in terms of the adoption of health technologies by healthcare professionals and patients in the year 2019.

Esta historia es de la edición February 2020 de Bio Spectrum.

Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.

Esta historia es de la edición February 2020 de Bio Spectrum.

Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.

MÁS HISTORIAS DE BIO SPECTRUMVer todo
Sartorius Stedim Biotech opens new centre for bioprocess innovation in US
Bio Spectrum

Sartorius Stedim Biotech opens new centre for bioprocess innovation in US

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, has opened its new centre for Bioprocess Innovation in Marlborough, Massachusetts in the US.

time-read
1 min  |
BioSpectrum India Jan 2025
Agilent introduces innovative Mito-rOCR assay kit for mitochondrial research
Bio Spectrum

Agilent introduces innovative Mito-rOCR assay kit for mitochondrial research

Agilent Technologies Inc. has announced the new MitorOCR Assay Kit.

time-read
1 min  |
BioSpectrum India Jan 2025
Qiagen launches AI-extension of Ingenuity Pathway Analysis for automatic interpretation of biological data
Bio Spectrum

Qiagen launches AI-extension of Ingenuity Pathway Analysis for automatic interpretation of biological data

Qiagen has announced the launch of Ingenuity Pathway Analysis (IPA) Interpret, a new feature designed to simplify and accelerate the interpretation of complex biological data.

time-read
1 min  |
BioSpectrum India Jan 2025
Parse Biosciences announces expansion of Evercode BCR product line
Bio Spectrum

Parse Biosciences announces expansion of Evercode BCR product line

Parse Biosciences, a leader in scalable single cell sequencing solutions, has announced the expansion of its Evercode BCR product line to enable applications in mice.

time-read
1 min  |
BioSpectrum India Jan 2025
New technology for unambiguous detection of HIV genome using tailored fluorogenic tests
Bio Spectrum

New technology for unambiguous detection of HIV genome using tailored fluorogenic tests

A team of scientists at Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), has developed a novel diagnostic technology known as the GQ Topology-Targeted Reliable Conformational Polymorphism (GQ-RCP) platform.

time-read
1 min  |
BioSpectrum India Jan 2025
Gene mutation likely cause for developing autism in early childhood: RGCB study
Bio Spectrum

Gene mutation likely cause for developing autism in early childhood: RGCB study

Autism, a developmental disorder that causes functional abnormalities in brain development, is caused by a combination of environmental and genetic factors with its symptoms manifesting in childhood as early as the age of two years.

time-read
1 min  |
BioSpectrum India Jan 2025
IIIT-Delhi unveils AI platform for discovering molecules that promote healthy ageing
Bio Spectrum

IIIT-Delhi unveils AI platform for discovering molecules that promote healthy ageing

A team of researchers from Indraprastha Institute of Information Technology Delhi (IIIT-Delhi) has developed AgeXtend, a groundbreaking artificial intelligence (AI)-based platform that is set to transform the search for molecules promoting healthy ageing.

time-read
1 min  |
BioSpectrum India Jan 2025
RSSDI study lays focus on Yoga and Diabetes Prevention
Bio Spectrum

RSSDI study lays focus on Yoga and Diabetes Prevention

Dr Jitendra Singh, Union Minister of State (Independent Charge) for Science and Technology, recently released the landmark study by Research Society for Study of Diabetes in India (RSSDI) on 'Yoga and Diabetes Prevention'.

time-read
1 min  |
BioSpectrum India Jan 2025
Dr Alok Khullar steps in as Group CEO of RJ Corp Healthcare
Bio Spectrum

Dr Alok Khullar steps in as Group CEO of RJ Corp Healthcare

RJ Corp Healthcare, a leading name in the healthcare sector through its renowned entities Cocoon Hospital and Cryoviva Stem Cell Bank, has announced the appointment of Dr Alok Khullar as Group Chief Executive Officer (CEO).

time-read
1 min  |
BioSpectrum India Jan 2025
Entod Pharmaceuticals on-boards Dr Anish Desai as Scientific & Research adviser
Bio Spectrum

Entod Pharmaceuticals on-boards Dr Anish Desai as Scientific & Research adviser

Mumbai-based Entod Pharmaceuticals has appointed Dr Anish Desai as its Scientific and Research Adviser.

time-read
1 min  |
BioSpectrum India Jan 2025